Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
Public ClinicalTrials.gov record NCT00316589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA-BN® (IMVAMUNE) Smallpox Vaccine in 18-55 Year Old Naive and Previously Vaccinated HIV Infected Subjects With CD4 Counts >200 - 750/µl.
Study identification
- NCT ID
- NCT00316589
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bavarian Nordic
- Industry
- Enrollment
- 581 participants
Conditions and interventions
Conditions
Interventions
- IMVAMUNE (MVA-BN) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Feb 28, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Jan 2, 2019
2006 – 2009
United States locations
- U.S. sites
- 34
- U.S. states
- 17
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Vaccine Research Clinic; University of Alabama at Birmingham | Birmingham | Alabama | 35294-2050 | — |
| Health for Life Clinic, PLLC | Little Rock | Arkansas | 72207 | — |
| Providence Clinical Research | Burbank | California | 91505 | — |
| Northern California Research | Carmichael | California | 95608 | — |
| CSI Clinical Trials, Inc. | Fountain Valley | California | 92708 | — |
| AltaMed Health Services | Los Angeles | California | 90022 | — |
| Alta Bates Summit Medical Center, East Bay AIDS Center | Oakland | California | 94609 | — |
| Benchmark Clinical Research | San Francisco | California | 94102 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Consultive Medicine | Daytona Beach | Florida | 32117 | — |
| Northpoint Medical, PA | Fort Lauderdale | Florida | 33308 | — |
| The Kinder Medical Group | Miami | Florida | 33133 | — |
| Infectious Diseases of NW Florida | Pensacola | Florida | 32504 | — |
| Palm Beach Center | West Palm Beach | Florida | 33409 | — |
| Atlanta ID Group | Atlanta | Georgia | 30309 | — |
| The CORE Center | Chicago | Illinois | 60612 | — |
| Northstar Medical Center | Chicago | Illinois | 60657 | — |
| Indiana University School of Medicine; Division of Infectious Disease | Indianapolis | Indiana | 46202-2859 | — |
| University of Iowa, Division of Infectious Diseases | Iowa City | Iowa | 52242 | — |
| Nemechek Health Renewal | Kansas City | Missouri | 64111 | — |
| St. Louis University, Center for Vaccine Dev. | St Louis | Missouri | 63104 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-5130 | — |
| Immuniodeficiency Clinic, ECMC | Buffalo | New York | 14260 | — |
| Universtity of Rochester School of Medicine | Rochester | New York | 14642 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104-6073 | — |
| Clinical Trials Research Services | Pittsburgh | Pennsylvania | 15206 | — |
| Brown Medical School | Providence | Rhode Island | 02906 | — |
| University of South Carolina | Columbia | South Carolina | 29203 | — |
| Vanderbilt University, AIDS Clinical Trials Center | Nashville | Tennessee | 37203 | — |
| Nicholaos C. Bellos, MD PA | Dallas | Texas | 75204 | — |
| Valley AIDS Council | Harlingen | Texas | 78550 | — |
| Diversified Medical Practices | Houston | Texas | 77027 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00316589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 2, 2019 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00316589 live on ClinicalTrials.gov.